| Call Number | 17413 |
|---|---|
| Day & Time Location |
T 5:30pm-8:20pm To be announced |
| Points | 1.5 |
| Grading Mode | Standard |
| Approvals Required | None |
| Instructor | Meghan M Fitzgerald |
| Type | SEMINAR |
| Method of Instruction | In-Person |
| Course Description | This course will use practical resources, site visits, and in-depth healthcare policy analysis to provide students with an overview of the major public healthcare companies that influence and shape the U.S. healthcare system and the current policy challenges faced by these entities in light of healthcare reform. Content will focus on Fortune 500 companies covering areas including pharmaceutical, clinical care, medical device, managed care, technology, and emerging business models. Students will be able to debate pressing issues such as pay-for-performance, transparency, technology innovation, consumerism reimbursement pressures, and the new role of government that affect all players; assess the intersection of public players with the new era of healthcare reform that is forcing innovation and change in a volatile market place; and discuss the drivers of cost growth in relation to pricing innovation and the influx of new patients under the exchanges. |
| Web Site | Vergil |
| Department | Health Policy & Management |
| Enrollment | 28 students (35 max) as of 9:14PM Wednesday, November 20, 2024 |
| Subject | Health Policy and Management |
| Number | P8585 |
| Section | 001 |
| Division | School of Public Health |
| Open To | GSAS, Public Health |
| Section key | 20241HPMN8585P001 |